211 results on '"Monsonego J"'
Search Results
2. Collaborateurs à la présente édition
3. Prévalence des génotypes d’HPV chez les femmes en France : implications pour le dépistage et la vaccination
4. Perception et impact psychologique du frottis anormal en France. Résultats comparatifs d’une enquête européenne
5. Nevirapine Use Is Associated with Higher Bone Mineral Density in HIV-1 Positive Subjects on Long-Term Antiretroviral Therapy
6. EUROGIN 2010 : feuille de route pour la prévention du cancer du col de l’utérus
7. Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course
8. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine
9. Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity
10. Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France
11. Cervical Cancer Prevention – Current Perspectives
12. Prévention du cancer du col utérin : enjeux et perspectives de la vaccination antipapillomavirus
13. Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy
14. HPV infections and cervical cancer prevention. Priorities and new directions. Highlights of EUROGIN 2004 International Expert Meeting, Nice, France, October 21–23, 2004
15. Chapitre 4 - Indications de la colposcopie
16. Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum
17. Cytologie en phase liquide dans le cadre du dépistage primaire du cancer du col utérin : une étude multi-centrique
18. Eurogin Roadmap 2017: triage strategies for the management of HPV-positive women in cervical screening programmes
19. Eurogin 2016 Roadmap:how HPV knowledge is changing screening practice
20. Eurogin 2015 Roadmap: How HPV knowledge is changing screening practice
21. The new challenges in the prevention of cervical cancer
22. Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines
23. Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region
24. Chapitre 4 - Indications de la colposcopie
25. Relative prevalence of high risk HPV genotypes in a US population: Insights before rollout of the next generation 9-valent HPV vaccine
26. DNA Content Measurement and In Situ Hybridization in Condylomatous Cervical Lesions
27. Indications, interprétation du test HPV et des marqueurs moléculaires
28. Apport du test HPV dans le dépistage primaire du cancer du col
29. Condylomes acuminés génitaux externes
30. Utilité clinique du génotypage
31. Indications et place du test HPV en pratique clinique
32. Aspects colposcopiques des lésions HPV associées Planches couleur
33. Vaccination HPV prophylactique, connaissances actuelles, modalités pratiques et nouveaux enjeux
34. Épidémiologie et histoire naturelle
35. Prise en charge du frottis anormal : apport de la colposcopie, du test HPV et des marqueurs moléculaires en pratique clinique
36. Dépistage du cancer du col utérin. Récents progrès et perspectives
37. ESGO consensus document on cervical cancer screening. European Society of Gynaecological Oncology
38. ESGO consensus document on cervical cancer screening. European Society of Gynaecological Oncology
39. HPV testing in management of cervical intraepithelial neoplasia (CIN)
40. Clinical consequences of HPV infection
41. Test HPV et dépistage du cancer du col utérin. Preuves, résistances et pratiques nouvelles
42. Corrigendum to “Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine” [Vaccine 28 (2010) 8065–8072]
43. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
44. Relative prevalence of high risk HPV genotypes in a US population: Insights before rollout of the next generation 9-valent HPV vaccine
45. Cancer anal et papillomavirus humains : une pathologie en miroir de celle du cancer du col utérin
46. O632 Results of the French APTIMA HPV screening evaluation (FASE Study)
47. EUROGIN 2007 roadmap on cervical cancer prevention
48. Genital warts: Incidence, medical management and costs in France
49. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia
50. New prevention strategies of HPV infection and cervical cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.